Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 06, 2018 02:00 ET | Source: Axovant Sciences Ltd.

Axovant Licenses Investigational Gene Therapy for Parkinson’s Disease from Oxford BioMedica and Announces Key Leadership Team Addition

Exclusive worldwide license to lentiviral vector gene therapy constitutes the first transaction of Axovant’s 2018 pipeline expansionFraser Wright, Co-Founder and former Chief Technology Officer of...
May 29, 2018 09:00 ET | Source: MIT Enterprise Forum (MITEF) of Cambridge

Network Your Way Through Tech Innovators at MITEF Startup Spotlight

MIT Enterprise Forum of Cambridge Annual Innovation Showcase to Feature 30+ Demos from Early Stage Companies Aspiring to Be the Next Unicorn Six Startups Representing MITEF Thailand to Participate ...
May 22, 2018 02:00 ET | Source: Spark Therapeutics, Inc.

Spark Therapeutics and Pfizer Announce Data from 15 Participants with Hemophilia B Showing Persistent and Sustained Factor IX Levels with No Serious Adverse Events

Annualized bleeding rate (ABR) for all 15 participants was reduced by 98 percent, while annualized infusion rate (AIR) was reduced by 99 percent as of the May 7, 2018 data cutoff Range of...
May 08, 2018 07:30 ET | Source: Spark Therapeutics, Inc.

Spark Therapeutics Reports First Quarter 2018 Financial Results and Recent Business Progress

PHILADELPHIA, May 08, 2018 (GLOBE NEWSWIRE) -- Spark Therapeutics (NASDAQ:ONCE), a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, announced...
May 01, 2018 07:30 ET | Source: Fundamental Markets

Detailed Research: Economic Perspectives on Vitamin Shoppe, Surmodics, Spark Therapeutics, QUANTENNA COMMS, Westinghouse Air Brake Technologies, and Resource Capital — What Drives Growth in Today's Competitive Landscape

NEW YORK, May 01, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders,...
May 01, 2018 07:30 ET | Source: Spark Therapeutics, Inc.

Spark Therapeutics to Host Conference Call on Tuesday, May 8 at 8:30 a.m. ET to Discuss First Quarter Results and Recent Business Highlights

PHILADELPHIA, May 01, 2018 (GLOBE NEWSWIRE) -- Spark Therapeutics (NASDAQ:ONCE), a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, will host a...
April 30, 2018 07:30 ET | Source: Spark Therapeutics, Inc.

Spark Therapeutics Sells Priority Review Voucher for $110 Million

PHILADELPHIA, April 30, 2018 (GLOBE NEWSWIRE) -- Spark Therapeutics (NASDAQ:ONCE), a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, today...
April 26, 2018 08:00 ET | Source: Poseida Therapeutics, Inc.

Poseida Therapeutics Presents Clinical Manufacturing Method for Durable, Persistent CAR-T Stem Cell Memory Therapies at World Orphan Drug Congress USA

SAN DIEGO, April 26, 2018 (GLOBE NEWSWIRE) -- Poseida Therapeutics Inc., a San Diego-based company translating best-in-class gene engineering technologies into lifesaving cell therapies, provided an...
April 23, 2018 03:30 ET | Source: Energias Market Research

Global Gene Therapy Market to Witness a CAGR of 14.6% during the 2018-2024: Energias Market Research Pvt. Ltd.

NEW YORK, April 23, 2018 (GLOBE NEWSWIRE) -- The global gene therapy market is expected to witness a CAGR of 14.6% and is projected to reach USD 558.7 million by 2024. This growth is attributed to...
April 19, 2018 01:00 ET | Source: NOVARTIS FINANCE S.A.

Novartis delivered a strong first quarter and acted to become a more focused medicines company

Net sales grew 4% (cc[1], +10% USD) mainly driven by: Entresto grew to USD 200 million, +126% (cc) driven by increased uptake world wide Cosentyx was USD 580 million, +35% (cc) with strong...